18

ANNUAL REPORT 2013-2014

FINANCES

FIXED ASSETS

CURRENT ASSETS

Debtors, prepayments and accrued income

Cash at bank and in hand

CAPITAL AND RESERVES

Capital FIP

Capital FIP sections

Congress reserve

Board of Pharmaceutical Practice reserve

Board of Pharmaceutical Sciences reserve

Regional forums reserve

Reserve HIV/AIDS

Reserve FIPEd

PROVISIONS

CURRENT LIABILITIES

31 DECEMBER 2013

606 011

330 908

2 621 824

2 952 732

3 558 743

1 307 121

504 686

650 000

79 320

142 010

4 859

10 000

29 691

2 727 687

65 326

765 730

3 558 743

619 203

854 865

1 605 034

2 459 899

3 079 102

1 004 744

484 815

650 000

68 979

186 402

4 859

10 000

57 541

2 467 340

60 000

551 762

3 079 102

TOTAL CURRENT ASSETS

TOTAL ASSETS

TOTAL CAPITAL AND RESERVES

TOTAL CAPITAL AND RESERVES AND LIABILITIES

31 DECEMBER 2012

INCOME

Membership fees

FIP World Congress revenues

Publications

Other income BPS

Sections income

FIP-Ed income

WHPA Counterfeit Campaign

Other income

EXPENSES

Personnel costs

Office costs

Meeting costs

Travel expenses (Ext. representation)

Website and IT costs

Depreciation of fixed assets

Special projects (incl. Reg. Forums & PET)

Direct FIP World Congress costs

Publications

Subventions

Expenses BPP

Expenses BPS

Sections costs

Maintenance fund

FIPEd expenses

WHPA Counterfeit Campaign

TB Campaign

Other expenses

Financial result

Appropriation of the results

BPP general reserves

BPS general reserves

Regional forums reserve

Section capital

Centennial reserve

Congress reserve

FIPEd reserve

FIP capital

TOTAL INCOME

TOTAL EXPENSES

OPERATING RESULT

NET RESULT BEFORE APPROPRIATION

TOTAL APPROPRIATION

ACTUALS 2013 BUDGET 2013 BUDGET vs ACTUALS ACTUALS 2012

909 579

1 949 856

3 069

1 096

84 391

47 918

60 937

48 721

3 105 567

722 566

150 654

75 266

29 689

53 490

16 484

61 120

1 075 340

29 336

209 500

91 004

94 143

64 520

15 000

110 768

60 937

-

-

2 859 817

245 750

14 597

260 347

10 341

( 44 392 )

-

19 871

-

-

( 27 850 )

302 377

260 347

850 000

1 715 000

5 000

-

120 000

80 000

-

20 000

2 790 000

890 000

220 000

100 000

50 000

60 000

25 000

15 000

1 066 500

60 000

9 500

102 000

50 000

120 000

15 000

35 000

-

-

2 000

2 820 000

( 30 000 )

30 000

-

-

-

-

-

-

-

-

-

-

59 579

234 856

( 1 931 )

1 096

( 35 609 )

( 32 082 )

60 937

28 721

315 567

( 167 434 )

( 69 346 )

( 24 734 )

( 20 311 )

( 6 510 )

( 8 516 )

46 120

8 840

( 30 664 )

200 000

( 10 996 )

44 143

( 55 480 )

-

75 768

60 937

-

( 2 000 )

39 817

275 750

( 15 403 )

260 347

10 341

( 44 392 )

-

19 871

-

-

( 27 850 )

302 377

260 347

888 119

3 000 221

3 774

6 720

103 049

75 729

68 362

39 529

4 185 503

740 031

125 426

101 416

35 256

34 224

16 529

21 384

2 287 554

7 090

43 113

92 909

68 617

84 664

15 000

83 224

68 362

14 551

-

3 839 350

346 153

16 455

362 608

8 436

( 13 242 )

( 9 335 )

18 385

( 300 000 )

196 220

( 7 495 )

469 639

362 608

BALANCE SHEET AT 31 DECEMBER 2013

After appropriation of the result for 2013

Expressed in EUR